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Abstract
Background: Fluorescent data obtained from real-time PCR must be processed by some method
of data analysis to obtain the relative quantity of target mRNA. The method chosen for data analysis
can strongly influence results of the quantification.
Results: To compare the performance of six techniques which are currently used for analysing
fluorescent data in real-time PCR relative quantification, we quantified four cytokine transcripts (IL-
1β, IL-6 TNF-α, and GM-CSF) in an in vivo model of colonic inflammation. Accuracy of the methods
was tested by quantification on samples with known relative amounts of target mRNAs.
Reproducibility of the methods was estimated by the determination of the intra-assay and inter-
assay variability. Cytokine expression normalized to the expression of three reference genes
(ACTB, HPRT, SDHA) was then determined using the six methods for data analysis. The best
results were obtained with the relative standard curve method, comparative Ct method and with
DART-PCR, LinRegPCR and Liu & Saint exponential methods when average amplification efficiency
was used. The use of individual amplification efficiencies in DART-PCR, LinRegPCR and Liu & Saint
exponential methods significantly impaired the results. The sigmoid curve-fitting (SCF) method
produced medium performance; the results indicate that the use of appropriate type of
fluorescence data and in some instances manual selection of the number of amplification cycles
included in the analysis is necessary when the SCF method is applied. We also compared
amplification efficiencies (E) and found that although the E values determined by different methods
of analysis were not identical, all the methods were capable to identify two genes whose E values
significantly differed from other genes.
Conclusion: Our results show that all the tested methods can provide quantitative values
reflecting the amounts of measured mRNA in samples, but they differ in their accuracy and
reproducibility. Selection of the appropriate method can also depend on the design of a particular
experiment. The advantages and disadvantages of the methods in different applications are
discussed.
Background
Reverse transcription (RT) followed by polymerase chain
reaction (PCR) is at present the most sensitive method for
the detection of specific RNA molecules. Quantification of
nucleic acids using the PCR has been significantly simpli-
fied by the development of the real-time PCR technique,
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accumulation is detected in every amplification cycle. In
biological applications examining gene expression, it is
mostly not necessary to know the absolute amount of the
measured mRNA (number of molecules in a sample). Rel-
ative mRNA quantification is an approach determining
the amount of target mRNA in samples relative each to
other. To compensate for differences in the RT-PCR input
quality and quantity, the target mRNA amount in each
sample is normalized to one or more internal controls.
Selection of an optimal normalization strategy has been
widely discussed [1,2] and is out of the scope of the
present study.
Fluorescent data obtained from real-time PCR must be
processed by some method of data analysis to obtain the
relative quantity of target mRNA. There are several tech-
niques used for real-time PCR data analysis and adequate
attention should be paid to the selection of the appropri-
ate method. Skern et al.[3] demonstrated that quantifica-
tion results can vary dramatically depending on the
method chosen for data analysis, and different analytical
approaches may even lead to opposing biological conclu-
sions. Methods for analysis of fluorescent real-time PCR
data used in relative mRNA quantification can be classi-
fied in various ways, depending on the criteria applied. All
methods determine the RT-PCR template quantity (desig-
nated "R0" throughout the present study) from the accu-
mulation of the PCR product during the amplification
process. Most techniques utilize exclusively the exponen-
tial phase of PCR to determine the amplification effi-
ciency (designated "E" throughout the present study) and
the R0 value [4,5]. The methods can be based on the deter-
mination of a "crossing point" between the PCR product
fluorescence and a chosen benchmark. The benchmark is
a point in the amplification curve (a graph of PCR product
fluorescence versus amplification cycle number) that rep-
resents the same amounts of PCR product in every ampli-
fication. The number of amplification cycles needed to
reach the benchmark is usually denoted as CP [6]. The
most commonly used form of the benchmark is the
threshold fluorescence (which can be set manually by the
user or automatically by the software of a real-time PCR
instrument), and the number of amplification cycles
needed for reaching the threshold fluorescence is usually
denoted as "Ct". The basic principle of the "threshold-
based" methods is the same – the lower the RT-PCR tem-
plate amount, the more amplification cycles are needed to
reach the threshold fluorescence. Apart from the "thresh-
old-based" methodologies that currently predominate,
there are methods which use linear regression analysis of
the fluorescent data from the exponential phase of PCR to
determine the E and/or R0 values [7,8]. Moreover, a
method that utilizes fluorescent data from the whole
course of the amplification curve has been developed [9-
11].
To compare the performance of six techniques which are
currently used for analyzing fluorescent data in real-time
PCR relative quantification, we determined the mRNA
levels of four pro-inflammatory cytokines (IL-1β, IL-6
TNF-α, and GM-CSF) in mice with trinitrobenzene sul-
phonic acid (TNBS) – induced colitis. TNBS-induced col-
itis is a widely used experimental model for studying gut
inflammatory processes such as ulcerative colitis and
Crohn's disease [12].
Results
Relative standard curves, determination of amplification 
efficiency
Relative standard curves of the analyzed targets are shown
in Figure 1. The difference in Ct between duplicate reac-
tions of the standard dilutions did not exceed 1% and it
was in the range 0.05% – 0.75% for ACTB and in the range
0.15%–1.0% for other genes. One exception was the 800-
fold dilution of IL-6 template where the difference in Ct
significantly exceeded 1% (it reached 2.3%) indicating
less reliable quantification at this dilution of the IL-6 tem-
plate. In GM-CSF (the gene with the highest Ct values),
the 800-fold template dilution did not produce a measur-
able fluorescent signal.
Amplification of the added luciferase mRNA showed very
similar Ct values in all six dilutions of the standard RNA
(arithmetical mean: 19.4, coefficient of variation: 1.28)
indicating a similar efficiency of reverse transcription in
all dilutions. Moreover, high correlation coefficients of
the standard curves (Fig. 1) indicate that both, the effi-
ciencies of reverse transcription and the PCR amplifica-
tion efficiencies are similar in all dilutions.
Amplification efficiency (E) representative for each gene
was determined from equation 7 in the relative standard
curve method (Table 1). Amplification efficiency for each
individual reaction was calculated using equation 10 in
the DART-PCR and LinRegPCR methods; in the Liu &
Saint-exp method, the amplification efficiency of each
reaction was calculated from equation 11. Table 1 shows
average amplification efficiencies determined for each
gene using the DART-PCR, LinRegPCR and Liu&Saint-exp
methods. On the whole, E values determined with the
LinRegPCR and Liu &Saint-exp methods were rather lower
and the ones determined with the DART-PCR method
were rather higher than the E values determined from rel-
ative standard curves. In genes with low-(ACTB, IL-1β)
and medium-(SDHA, HPRT, TNF-α) Ct values, the aver-
age amplification efficiencies determined by the four
methods were close to 1.0; in genes with high-Ct values
(IL-6, GM-CSF), the efficiencies were lower. However, thePage 2 of 14
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Relative standard curvesFigure 1
Relative standard curves. The standard curves were generated by the Mx3000P software by plotting cycles at threshold fluo-
rescence (Ct) against the logarithmic values of standard RNA amounts. Quantities of standard RNA were expressed as dilution 
factors of the RNA preparation (1, 0.5, 0.25, 0.125, 0.0125, 0.00125). Correlation coefficients (square values – r2) and amplifi-
cation efficiencies (E) are shown. SYBRGreen I fluorescences were corrected with passive reference dye (ROX) fluorescences 
(„dRn“).
BMC Molecular Biology 2007, 8:113 http://www.biomedcentral.com/1471-2199/8/113amplification efficiency of the gene with the highest Ct
values (GM-CSF, average Ct value from dilutions 1× –
80×: 29.79) was higher than the efficiency of the other
„high-Ct“ gene (IL-6, average Ct value from dilutions 1× –
80×: 26.69).
Determination of target mRNA quantity in known sample 
dilutions
Linear regression analysis generated by plotting values of
target mRNA quantities (R0) against diluting factors of the
total RNA preparation was performed to evaluate the
accuracy how the R0 values determined by different meth-
ods of real-time PCR data analysis reflect the RT-PCR tem-
plate dilutions. The relationship between determined R0
values and sample dilutions was closest in the standard
curve method, comparative Ct method, DART-PCR
method with average E values, Liu & Saint-exp method
with average E values and the combined LinRegPCR-Ct
method using average E values, where average Pearson's
correlation coefficients (obtained from the coefficients of
the seven genes) reached value at least 0.999 (Table 2). In
the sigmoid curve-fitting method the average Pearson's
correlation coefficient was 0.9953; manual selection of
the cut-off cycle (see Methods) was necessary in SDHA,
improving the value of the Pearson's correlation coeffi-
cient from 0.9986 to 0.9999. In the remaining three meth-
ods (LinRegPCR, DART-PCR and Liu & Saint-exp methods
with individual E values) the average Pearson's correlation
coefficients reached values between 0.9577 and 0.9733
(Table 2). In most cases, the Pearson's correlation coeffi-
cients in the gene with the highest Ct values (GM-CSF)
were lower than in other genes.
We normalized the quantity of cytokines (IL-1β, IL-6,
TNF-α, GM-CSF) with the quantity of one reference gene
(ACTB, a "low-Ct" gene or HPRT, a "high-Ct" gene) or
with the normalization factor to test the influence of the
normalization on the accuracy of the evaluated methods.
Normalization factors were determined in all dilutions of
the RT-PCR template using the geNorm software. The
parameter "M", calculated by the software, is a measure of
the gene expression stability; the lower is the M value the
higher is the gene expression stability. The parameter "V2/
V3" (i.e., the third gene added to the two genes) represents
pairwise variations determining the optimal number of
reference genes which should be included for calculation
of a reliable normalization factor [13]. Parameters of the
geNorm software calculated for the three reference genes
(used for the normalization factor calculation) are shown
in Table 3. Values of the M parameter for ACTB, SDHA,
and HPRT were similar within all methods of analysis.
However, comparison of the M values between individual
Table 1: Amplification efficiency determined by various methods of real-time PCR data analysis. Arithmetical means ± SD and 
coefficients of variation (in parentheses) are shown.
Gene/Method Standard curve DART-PCR LinRegPCR Liu&Saint-exp
IL-1β 0.998 1.033 ± 0.061 (5.95) 0.950 ± 0.074 (7.76) 0.974 ± 0.033 (3.42)
IL-6 0.900 0.912 ± 0.046 (5.05) 0.881 ± 0.075 (8.51) 0.870 ± 0.029 (3.35)
TNF-α 1.012 1.033 ± 0.024 (2.32) 0.974 ± 0.072 (7.45) 0.991 ± 0.032 (3.32)
GM-CSF 0.918 0.978 ± 0.044 (4.49) 0.932 ± 0.063 (6.75) 0.898 ± 0.013 (1.44)
ACTB 0.981 1.086 ± 0.046 (4.21) 0.999 ± 0.031 (3.10) 0.978 ± 0.044 (4.53)
SDHA 0.967 1.072 ± 0.052 (4.88) 0.980 ± 0.064 (6.55) 1.017 ± 0.044 (4.27)
HPRT 1.022 1.069 ± 0.064 (5.95) 0.978 ± 0.109 (11.1) 0.976 ± 0.048 (4.49)
Table 2: Pearson's correlation coefficients obtained from the linear regression plotting R0 values against diluting factors of the total 
RNA (RT-PCR template). The R0 values were obtained by transformation of fluorescence data using the following methods for real-
time PCR data analysis: St cur, relative standard curve; Comp, comparative Ct; SCF, sigmoid curve-fitting; DART ind E, DART-PCR 
with individual E values; DART av E, DART-PCR with average E values; Liu&S ind E, Liu & Saint-exp with individual E values, Liu&S av 
E, Liu & Saint-exp with average E values; LinReg ind E, LinRegPCR (using individual E values); LinReg-Ct av E, LinRegPCR combined 
with Ct (using average E values).
Gene/Method St cur Comp SCF DART ind E DART av E Liu&S ind E Liu&S av E LinReg ind E LinReg-Ct av E
IL-1β 0.9993 0.9996 0.9960 0.9924 0.9997 0.9697 0.9994 0.9113 0.9994
IL-6 0.9998 0.9998 0.9951 0.9745 0.9993 0.9510 0.9996 0.9391 0.9997
TNF-α 0.9996 0.9998 0.9987 0.9910 0.9989 0.9622 0.9996 0.9835 0.9996
GM-CSF 0.9980 0.9980 0.9803 0.9620 0.9985 0.9277 0.9975 0.9426 0.9980
ACTB 0.9991 0.9992 0.9973 0.9435 0.9972 0.9915 0.9998 0.9828 0.9984
SDHA 0.9998 0.9999 0.9999 0.9799 0.9999 0.9872 0.9999 0.9902 0.9999
HPRT 0.9996 0.9995 0.9997 0.9699 0.9990 0.9662 0.9994 0.9545 0.9997
Average 0.9991 0.9994 0.9953 0.9733 0.9990 0.9651 0.9993 0.9577 0.9992Page 4 of 14
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fold higher in the three methods utilizing individual E val-
ues (DART-PCR, Liu & Saint-exp and LinRegPCR with
individual E) than in other methods. Similarly, values of
the V2/3 parameter were higher in the three methods uti-
lizing individual E values than in other methods indicat-
ing a requirement of higher amount of reference genes to
calculate a reliable normalization factor.
Since the determined quantity of cytokines and reference
genes should reflect the template dilutions by the same
manner, the same normalized quantity of cytokines
should be determined in each dilution. Variability of the
normalized quantity between the known template dilu-
tions can then be used as a measure of the quantification
accuracy – the lower the variability between dilutions the
higher the accuracy of quantification. Figure 2 shows coef-
ficients of variation (CV) for normalized quantity of IL-1β
in six RT-PCR template dilutions (similar results were
obtained for IL-6, TNF-α, and GM-CSF; data not shown).
In most methods, similar CV values were found after nor-
malization to the normalization factor, to the „low Ct“-
gene or to the „high Ct“-gene (which is caused by similar
expression stability of the three reference genes as shown
in Table 3); differences detected by the three methods uti-
lizing individual E values were not consistent nor among
the three methods neither among the four measured
cytokines. On the other hand, comparison of CV values
between individual methods of analysis showed markedly
higher coefficients of variation in the three methods uti-
lizing individual E values (DART-PCR, Liu & Saint-exp
and LinRegPCR with individual E) than in other methods
(Fig. 2).
Intra-assay and inter-assay variability
Reproducibility of the tested methods for real-time PCR
data analysis was evaluated by performing experiments
where the intra- and inter-assay variability was measured.
Two genes were selected for the measurements – IL-1β,
representing a target with low Ct values and IL-6, repre-
senting a target with high Ct values. Results from the
experiment measuring the intra-assay variability are
shown in Table 4. In both genes, the lowest coefficients of
variation were obtained when the following methods of
real-time PCR data analysis were used for the determina-
tion of target mRNA quantity (R0): standard curve
method, comparative Ct method, DART-PCR method
with average E values, Liu & Saint-exp method with aver-
age E values and the combined LinRegPCR-Ct method
(using average E values). Using the sigmoidal curve-fitting
method, the coefficients of variation were markedly
higher. The highest coefficients of variation were obtained
using the LinRegPCR method, DART-PCR method and Liu
& Saint-exp method with individual E values. Similar
results (except of the SCF method) were obtained in the
experiment measuring the inter-assay variability (Table
5). Coefficients of variation calculated from Ct values of
15 replicate PCR reactions in the intra-assay experiment
were 0.52 for IL-1β and 0.63 for IL-6; in the inter-assay
experiment, the coefficients were 1.1 for IL-1β and 1.18
for IL-6.
In the standard curve method, comparative Ct method,
and the three methods using average E values (DART-PCR,
Liu & Saint-exp, LinRegPCR-Ct – with average E), the
intra-assay variability was higher in IL-6 than in IL-1β; a
similar trend was found for the inter-assay variability
(except of two methods – DART-PCR and Liu & Saint-exp,
which showed similar values for both genes). The three
methods (DART-PCR, Liu & Saint-exp, LinRegPCR-Ct)
utilizing individual E values (and showing high CV val-
ues) gave inconsistent results and in some cases, the deter-
mined intra-assay variability was even higher than the
inter-assay variability. The CV values obtained in the
intra- and inter-assay experiment with the SCF method
were comparable, and they were higher in IL-6 than in IL-
1β which is in accordance with the five well-working
methods (Table 4, Table 5).
Normalized cytokine expression in the experimental 
samples
Figure 3 and Figure 4 show normalized expression of IL-
1β and IL-6 as determined by all the tested methods of
real-time PCR data analysis in the experimental samples.
Estimation of IL-1β and IL-6 expression using the Kruskal-
Wallis test showed that differences between the experi-
Table 3: Parameters of the geNorm software for ACTB, SDHA, and HPRT. The parameters were determined from quantities (R0 
values) of the three genes in the RT-PCR template dilutions. M – measure of the gene expression stability, V2/V3 – pairwise variations 
determining the optimal number of reference genes. Indicated methods for real-time PCR data analysis were used for the 
transformation of fluorescence data to the R0 values. Designation of the methods is the same as in Table 2.
Parameter/Method St cur Comp SCF DART ind E DART av E Liu&S ind E Liu&S av E LinReg ind E LinReg-Ct av E
M for ACTB 0.159 0.161 0.315 0.598 0.200 0.544 0.213 1.772 0.276
M for SDHA 0.187 0.191 0.293 0.578 0.183 0.538 0.326 1.549 0.246
M for HPRT 0.181 0.165 0.324 0.631 0.226 0.626 0.228 1.349 0.338
V2/V3 0.057 0.060 0.097 0.190 0.071 0.195 0.107 0.564 0.109Page 5 of 14
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LinRegPCR method with individual E values and P ≤
0.001 with all other methods). Estimation of the differ-
ence in IL-1β and IL-6 expression between the group Un
(untreated colitic animals) and the other groups of ani-
mals (with the Mann-Whitney test) showed significantly
increased expression of these cytokines in the untreated
colitic animals, using all the tested methods of real-time
PCR data analysis. All methods also detected a significant
decrease of the two cytokines expression after treatment B
(with lower level of significance using LinRegPCR or
DART-PCR methods with individual E values). In the case
of IL-1β, some of the methods also detected significant
decrease in the cytokine expression after treatments A, or
C.
In TNF-α and GM-CSF, significant differences were found
only between the group of untreated colitic animals (Un)
and the group of sham control animals (Sh). In TNF-α, all
the tested methods of real-time PCR data analysis showed
Coefficients of variation for normalized quantity of IL-1β in serial dilutions of the RT-PCR templateFigure 2
Coefficients of variation for normalized quantity of IL-1β in serial dilutions of the RT-PCR template. Quantities of IL-1β, HPRT, 
SDHA and ACTB mRNAs (the R0 values) were determined in each dilution of the RT-PCR template (six dilutions of total 
RNA) using all the tested methods of real-time PCR data analysis. The amount of IL-1β mRNA in each dilution was then 
divided by the relative amount of HPRT, ACTB, or by the normalization factor (NF, geometric mean of HPRT, SDHA and 
ACTB amounts) of the dilution. Arithmetical mean, standard deviation and coefficient of variation of the normalized IL-1β 
quantity for each type of normalization (HPRT, ACTB, NF) and each method of real-time PCR data analysis was then calcu-
lated. Coefficients of variation (CV) are shown: the first columns are CV values after normalization with the normalization fac-
tor, the second columns are CV values after normalization with ACTB, and the third columns are CV values after 
normalization with HPRT. Methods for real-time PCR data analysis: St. C., relative standard curve; COM, comparative Ct; SCF, 
sigmoid curve-fitting; DAR iE, DART-PCR with individual E values; DAR aE, DART-PCR with average E values; L&S iE, Liu & 
Saint-exp with individual E values, L&S aE, Liu & Saint-exp with average E values; LR iE, LinRegPCR (using individual E values); 
LR-Ct, LinRegPCR combined with Ct (using average E values)
Table 4: Intra-assay variability. Coefficients of variation calculated from R0 values of 15 replicate PCR reactions. Indicated methods for 
real-time PCR data analysis were used for the transformation of fluorescence data to the R0 values. Designation of the methods is the 
same as in Table 2.
Gene/Method St cur Comp SCF DART ind E DART av E Liu&S ind E Liu&S av E LinReg ind E LinReg-Ct av E
IL-1β 5.95 5.95 17.1 60.6 7.63 25.03 7.33 49.08 5.71
IL-6 9.94 9.94 22.3 83.6 10.2 43.7 9.28 53.5 9.73Page 6 of 14
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Un than in the group Sh. In GM-CSF, the difference
between the group Un and Sh was detected as significant
only with the standard curve method, comparative Ct
method, and the three methods utilizing average E values
(DART-PCR, Liu & Saint-exp, LinRegPCR-Ct – with aver-
age E); the methods which used individual E values
(DART-PCR, Liu & Saint-exp, LinRegPCR-Ct – with indi-
vidual E) did not detect the difference as statistically sig-
nificant (data not shown).
Discussion
To compare the methods currently used for analyzing flu-
orescence data in real-time PCR relative quantification, we
determined mRNA levels of four pro-inflammatory
cytokines in the in vivo model of colonic inflammation,
using six different techniques. Three housekeeping genes
were also quantified to serve as reference genes for the
normalization of cytokine mRNA quantity. The compared
methods differ principally in the mathematical function
used for modeling the PCR process, in the necessity to cre-
ate a dilution series of the RT-PCR template, in the neces-
Table 5: Inter-assay variability. Coefficients of variation calculated from R0 values of 8 PCR reactions. Indicated methods for real-time 
PCR data analysis were used for the transformation of fluorescence data to the R0 values. Designation of the methods is the same as in 
Table 2.
Gene/Method St cur Comp SCF DART ind E DART av E Liu&S ind E Liu&S av E LinReg ind E LinReg-Ct av E
IL-1β 12.4 12.4 15.3 79.7 18.3 30.3 17.7 68.8 11.2
IL-6 18.6 17.1 20.5 65.5 17.7 40.2 17.5 53.8 16.2
IL-1β mRNA expressionFigure 3
IL-1β mRNA expression. Quantities of IL-1β, HPRT, SDHA and ACTB mRNAs (the R0 values) were determined in each sample 
using all the tested methods of real-time PCR data analysis. The amount of IL-1β mRNA in each sample was then divided by the 
normalization factor (geometric mean of HPRT, SDHA and ACTB amounts) of the sample. Values are arithmetical means + 
SEM, n = 5–8. Statistical significance of the differences between the group of untreated colitic animals (Un) and other groups of 
animals was assessed with the Mann-Whitney test: * P ≤ 0.05, ** P ≤ 0.01. Methods for real-time PCR data analysis: Stand curv, 
relative standard curve; Comparat, comparative Ct; SCF, sigmoid curve-fitting; DART ind E, DART-PCR with individual E val-
ues; DART av E, DART-PCR with average E values; Liu&S ind E, Liu & Saint-exp with individual E values, Liu&S av E, Liu & Saint-
exp with average E values; LinReg ind E, LinRegPCR (using individual E values); LinReg-Ct av E, LinRegPCR combined with Ct 
(using average E values) Designation of the animal groups: the first columns, control sham animals (Sh); the second columns, 
untreated colitic animals (Un); the third columns, colitic animals with the treatment A; the fourth columns, colitic animals with 
the treatment B; the fifth columns, colitic animals with the treatment CPage 7 of 14
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determination, in the way of calculation of the target
mRNA quantity (R0).
Most of the methods utilize fluorescence data only from
the exponential phase of PCR amplification (the exponen-
tial model of PCR) and require setting a threshold fluores-
cence (common for all compared samples) to determine
the Ct value ("threshold-based" methodologies). The rel-
ative standard curve method determines target mRNA rel-
ative quantities in samples from known relative quantities
of standard RNA or cDNA. To obtain correct results,
amplification efficiency in the dilutions of the standard
preparation and in samples must be similar. The E value
determined from the slope of the standard curve (or from
a dilution series of a representative sample) can be uti-
lized for the calculation of the target mRNA quantity (R0)
in techniques of relative quantification, which can be
denoted as "comparative Ct methods". Equation 5 can be
used for the transformation of Ct values to the R0 values;
the only parameter which differs among the compared
samples is Ct. The term "comparative Ct method" is most
frequently used for the " 2-∆∆Ct " method introduced by
Livak [14]; in this method E is assumed to be equal to 1
and the formula for the R0 calculation can be modified to
R0 = 2-Ct. Pfaffl's model of the comparative Ct method [15]
incorporates a correction for amplification efficiency dif-
fering from the optimal value 1. Most published versions
of the comparative Ct method use normalization of the
target gene quantity to a reference gene quantity, very
often referring to one of the samples (a "calibrator" sam-
ple), and the formula for calculation of the target gene rel-
ative quantity is more complicated [14-19]. In any case,
formulas used in comparative Ct methods for calculation
of the normalized relative amount of target gene quantity
can be derived from equation 5. Pfaffl et al.[20] developed
the software named REST (Relative Expression Software
Tool) which can perform the comparative Ct quantifica-
tion in two experimental groups (with or without the E
value correction) followed by a statistical test. In the
present study, we used E values determined for each gene
from the relative standard curves and calculated the R0
value for each gene in each sample using the equation 5.
The cytokine genes quantity was then normalized with the
factor obtained from the quantities of three reference
genes.
In the method proposed by Liu and Saint [21], the ampli-
fication efficiency for each sample is determined from the
amount of fluorescence and the number of cycles at two
arbitrary fluorescence thresholds along the exponential
phase of the PCR amplification (Eq 11). The fluorescence
IL-6 mRNA expressionFigure 4
IL-6 mRNA expression. Quantities of IL-6, HPRT, SDHA and ACTB mRNAs (the R0 values) were determined in each sample 
using all the tested methods of real-time PCR data analysis. The amount of IL-6 mRNA in each sample was then divided by the 
normalization factor (geometric mean of HPRT, SDHA and ACTB amounts) of the sample. Values are arithmetical means + 
SEM, n = 5–8. Statistical significance of the differences between the group of untreated colitic animals (Un) and other groups of 
animals was assessed with the Mann-Whitney test: * P ≤ 0.05, ** P ≤ 0.01. Designation of the methods and animal groups is the 
same as in Figure 3.Page 8 of 14
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or a threshold level common for all reactions can be set.
In the first case equation 4 is used for the R0 calculation,
and in the second case equation 4 or equation 5 can be
used. We compared the quantification results obtained
with this method using either individual E values (deter-
mined for each amplification) or using an average E value.
Ramakers et al.[7] developed a computer program entitled
LinRegPCR, which determines the target mRNA quantity
(R0) and amplification efficiency (E) by linear regression
analysis (Eq 9, Eq 10) of fluorescence data obtained from
real-time PCR. Like the above-mentioned methods, linear
regression exploits only the exponential phase of PCR
amplification, but the method is not "threshold-based" –
no benchmark (threshold fluorescence) is needed for the
calculations. We analyzed our fluorescence data with the
LinRegPCR software and with a technique which com-
bines linear regression analysis and the threshold-based
methodology. The combined technique (we have desig-
nated it "LinRegPCR-Ct") utilizes E values determined by
the LinRegPCR software (for calculation of an average E)
and Ct values determined by the Mx3000P real-time PCR
instrument. A similar strategy was applied by Karlen et
al.[22] and Schefe et al.[23]. The DART-PCR program
developed by Peirson et al.[8] provides an automated
analysis of real-time PCR fluorescence data utilizing the
combined approach (linear regression for E determina-
tion and threshold fluorescence for Ct determination).
Similarly as for LinRegPCR, we compared the quantifica-
tion results obtained with DART-PCR using individual or
average E values for the R0 calculation.
The method in which a sigmoid mathematical model that
fits the kinetics of the whole real-time PCR process is
applied [9,10], represents an approach completely differ-
ent from the above-mentioned techniques. The sigmoid
curve-fitting (SCF) method utilizes all fluorescence data
recorded during the amplification process (not only the
data from the exponential phase) for determination of the
R0 value. Moreover, the method can carry out quantifica-
tion without the knowledge of amplification efficiency
and without determination of Ct. Rutledge [11] found
that amplification cycles within the plateau phase of PCR
deviate from that predicted by sigmoid curve-fitting, and
their exclusion from the curve-fitting process is necessary.
He proposed the selection of a cut-off cycle beyond which
further cycles are excluded from the fitting of the amplifi-
cation curve. The criterion used for the selection of the
cut-off cycle was based on repetitive curve-fitting in which
the last cycle was sequentially excluded and the R0 value
was calculated at each individual curve-fitting. Plotting
the calculated R0 values against the cut-off cycle revealed a
highly regular pattern in which the calculated R0 value
decreased with subsequent cycle removal, and after reach-
ing a minimum a small increase in the R0 value appeared;
the minimum-calculated R0 value was selected as the
resulting R0. In our work, we found that the shape of the
graph of R0 dependency on the cut-off cycle can be influ-
enced by fluorescence data provided by the real-time PCR
system. Using background-subtracted fluorescence data
from the Mx 3000P system (Stratagene), we were not able
to identify the regular trend of the curve R0 vs cut-off cycle
as described by Rutledge [11]; background-subtracted
data from Opticon2 DNA Engine (MJ research Inc.) were
used in Rutledge's study. On the other hand, raw fluores-
cence data from Mx 3000P provided a regular pattern of
the R0 value as a function of the cut-off cycle (R0 decrease
followed by a small increase after reaching a minimum) in
most curves. In some instances the cut-off cycle with the
minimal R0 value was determined in the region of the
amplification curve which contained an insufficient
amount of fluorescent data, and manual selection was
necessary. Karlen et al.[22] testing the performance of sev-
eral methods for real-time PCR data analysis found the
sigmoid curve-fitting method (together with the method
fitting PCR amplification to the exponential function) as
the least suitable for quantitative PCR analysis. On the
contrary, our results indicate that the SCF method can
provide reasonable results. Similarly, Qiu et al.[24]
obtained comparable results using the SCF method and a
classic threshold-based method. The differences in the
SCF method performance were probably caused by differ-
ent number of amplification cycles included into the fit-
ting process. An appropriate selection of the optimal cycle
number (exclusion of late cycles) is probably the key fac-
tor for obtaining satisfactory performance of the SCF
method, but the choice of a suitable criterion for determi-
nation of the "cut-off cycle" can be difficult (as discussed
above).
In our study, we determined amplification efficiencies (E)
of seven genes using four methods of real-time PCR data
analysis, and found some differences in the determined E
values. On the other hand, all the methods were capable
to identify the two genes whose E values significantly dif-
fered from the others. Interestingly, the amplification effi-
ciencies determined by the two methods which employ
linear regression for the calculation (DART-PCR and Lin-
RegPCR) were less close each to other than to efficiencies
determined by the relative standard curve or Liu & Saint-
exp method. This can be caused by differences in the way
the two methods determine the exponential phase of
amplification. Lower amplification efficiency found by all
tested methods in two genes with high Ct values (IL-6 and
GM-CSF) could suggest some influence of Ct value on the
determination of the E value. However, the comparison of
E and Ct values in the two „high-Ct genes“ indicates that
a higher Ct value is not necessarily leading to obtaining of
a lower E value. This finding is in accordance with resultsPage 9 of 14
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value on Ct value; the authors defined the amplicon and
primer sequences as the main factor influencing the effi-
ciency of amplification.
To compare the accuracy of relative quantification con-
ducted with application of different methods for real-time
PCR data analysis, we determined quantities of seven tar-
get mRNAs in serially diluted preparation of total RNA.
We found that R0 values determined with the relative
standard curve method, comparative Ct method and with
the three methods using an average E value for the calcu-
lations (DART-PCR, Liu & Saint-exp, LinRegPCR-Ct – with
average E) most accurately reflected the RT-PCR template
dilutions. Less effective was the SCF method, and the
worst results were obtained with the three methods which
used individual E values (DART-PCR, Liu & Saint-exp, Lin-
RegPCR – with individual E). Normalization of cytokines
mRNA quantity (to a single reference gene or to a normal-
ization factor calculated from reference genes with com-
parable expression stability) did not influence the
differences in the performance of the methods for real-
time PCR analysis tested in our study. On the other hand,
our results indicate that targets with high Ct values can be
quantified with a lower accuracy than targets with
medium and low Ct values. Reproducibility of the tested
methods was estimated by determination of the intra- and
inter-assay variability and showed the same result as the
accuracy test. The highest reproducibility was found in the
relative standard curve method, comparative Ct method
and in the three methods using an average E value for cal-
culations. The SCF method was less precise, and the worst
results were obtained with the three methods which used
individual E values. Our results also showed a negative
effect of higher Ct values on the reproducibility of the
tested methods.
Comparing results of normalized expression of IL-1β and
IL-6 in the experimental samples, all the tested methods
were able to detect significant changes between the con-
trol animals, untreated colitic animals, and animals
undergoing treatment B. The effects of treatments A or C
on the IL-1β mRNA level were detected as statistically sig-
nificant only by some of the tested methods. In TNF-α and
GM-CSF, all the tested methods showed higher amount of
the cytokines in untreated colitic animals than in control
animals, hovewer the three methods which utilized indi-
vidual E values (DART-PCR, Liu & Saint-exp, LinRegPCR-
Ct – with individual E) were not able to detect the differ-
ence in GM-CSF expression as statistically significant.
Application of corrections for individual sample efficiency
should theoretically improve the accuracy and reproduci-
bility of the quantification. But our results showed that,
on the contrary, the use of individual E values for the R0
calculation impaired the quantification. Similar findings
were presented in studies where linear regression was uti-
lized for the calculation of individual amplification effi-
ciencies [8,22,23]. We used two approaches for
determination of the individual amplification efficiencies
– linear regression (in DART-PCR method and LinReg
PCR method which differ in the way of exponential phase
determination) and the method which utilize setting of
two fluorescence thresholds along the exponential phase
(Eq 11). Independently on the way used for the calcula-
tion of E values, all the three methods showed the nega-
tive effect of the individual E values on the quantification
which indicates that this is probably a feature connected
with the limited precision of individual data and not with
the mathematical approach used for E value determina-
tion. The individual E values (determined with linear
regression or with the Eq 11) are derived from individual
sample kinetics represented by the fluorescence values
obtained in particular amplification cycles. Above men-
tioned results suggest that fluorescence values detected by
real-time systems do not reflect the reaction kinetics with
the precision which would be sufficient for reliable E
value determination from the exponential phase of the
individual amplification. The average E value obtained
from the group of amplifications eliminates individual
imprecisions enabling to find a reliable value of the
amplification efficiency.
Conclusion
Choosing the appropriate method for real-time PCR data
analysis can depend on conditions in a particular applica-
tion. The relative standard curve method is widely used
and can provide reliable results, especially in the case
when the same quality of RT-PCR template is ensured in
standards and samples. Sometimes this is not possible, for
instance if the quantification is performed on different tis-
sue types, or if the amount of tissue is limited (e.g. tissue
biopsies, preimplantation embryos). Similar restrictions
apply also for comparative Ct methods. These methods
require serial dilutions of a representative sample to deter-
mine the E value which is usually done in a validation
experiment preceding a series of measurements. This
approach enables to measure more samples in a PCR run
(no standard curve in the run), but identical conditions
for all measurements must be ensured. The other three
methods tested in the present study (Liu & Saint-exp,
DART-PCR, LinRegPCR) do not require serial dilutions of
the RT-PCR template for E value determination. We found
that these methods provide more reliable results when an
average E value and not individual E values (determined
for each amplification) are used for the R0calculation. The
Liu & Saint-exp method is simple – the formula for E value
calculation can be easily implemented into spreadsheet
programs such as Microsoft Excel and the selection of the
exponential phase of amplification is not difficult (thePage 10 of 14
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line). Our results with the Liu & Saint-exp quantification
showed that although the criterion for selection of the
exponential phase is subjective, reasonable results can be
obtained if the same criterion is applied for all compared
samples. The LinRegPCR and DART-PCR methods use a
more complicated calculation (based on linear regres-
sion) for the E value determination. The DART-PCR soft-
ware combining the linear regression analysis with
threshold-based methodology enables R0 values to be cal-
culated using an average E value; the LinRegPCR software
do not enable the automated use of an average E value,
but manual combination with a threshold-based tech-
nique is possible. The SCF method differs from all the
other methods in the mathematical model used for the
calculations – it is not necessary to look for the exponen-
tial phase of amplification and to determine the E value.
For reliable quantification with this method, fluorescence
data including at least the beginning of the plateau phase
are needed, which can be a disadvantage when genes with
low expression are quantified or when low sample
amounts are available. In summary, our results show that
all the tested methods for real-time PCR data analysis can
provide quantitative values reflecting the amounts of
measured mRNA in samples, but they differ in their accu-
racy and reproducibility. Although selection of the appro-
priate method can be limited by the design of a particular
experiment (e.g. tissue type, gene abundance, number of
experimental groups) the use of more than one analytical
method is recommended for validation of results.
Methods
Animal experiment, sample preparation, and real-time 
PCR
All the fluorescent data used in this study were obtained
from a previous study examining the effects of plant
essential oils thyme and oregano on trinitrobenzene sul-
phonic acid (TNBS)-induced colitis in mice [25]. Briefly,
colitis was induced in male Balb/c mice by administration
of TNBS and the animals were treated with three increas-
ing concentrations of the plant oils (treatments A, B and
C; the group of untreated colitic animals was designated
as Un and sham control group as Sh in the present study).
Total RNA was isolated from the strips of colonic tissue
with TRIzol Reagent (Invitrogen Life Technologies, Karl-
sruhe, Germany). The RNA preparations were then
cleaned and DNase I treated with an RNeasy Micro kit
(Qiagen, Hilden, Germany). Complementary DNA
(cDNA) was then synthesized from the RNA (0.75 µg
from each sample) using Superscript™ II Rnase H-Reverse
Transcriptase (Invitrogen Life Technologies; for more
details see [25])
Serial dilutions of total RNA (1× – i.e. no dilution, 2×, 4×,
8×, 80×, 800×) were prepared from the pool of colon RNA
obtained by combining aliquots of samples from the col-
itic animals. Complementary DNA was then synthesized
from each dilution as described above. To compensate for
different RNA amounts in the reverse transcription reac-
tions yeast total RNA was added in appropriate amounts
to the colon RNA dilutions (all oligonucleotide primers
were checked so as not to create any PCR product on the
yeast cDNA template). The cDNAs then served as a PCR
template for construction of relative standard curves.
Amplifications performed on the standard cDNAs were
also utilized for comparison of the accuracy of quantifica-
tion by the tested methods for real-time PCR data analysis
(determination of known sample dilutions); in the rela-
tive standard curve method two sets of total RNA dilutions
(and cDNA preparations) were used – one set was utilized
for the construction of standard curves and the other set
served as known sample dilutions.
To test the efficiency of reverse transcription in the serial
dilutions of standard RNA, identical amount (10 pg) of
luciferase mRNA (Promega, Madison, WI) was added into
the six RNA dilutios (1×, 2×, 4×, 8×, 80×, 800×) and then
cDNA was synthesized from each dilution (as described
above).
PCR reactions were carried out in duplicates using
SYBRGreen I as a fluorescent detection dye and they were
performed in the real-time PCR system Mx 3000P (Strata-
gene, La Jolla, CA). Background-subtracted fluorescences
were used for data analysis by all tested methods except
for the sigmoid curve-fitting method, where raw fluores-
cences were used (see below). Specific oligonucleotide
primers for amplification of mouse interleukin 1 beta (IL-
1β), interleukin 6 (IL-6), tumor necrosis factor alpha
(TNF-α), granulocyte macrophage-macrophage colony
stimulating factor (GM-CSF), beta actin (ACTB), hypox-
anthine guanine phosphoribosyl transferase 1 (HPRT)
and succinate dehydrogenase complex subunit A (SDHA)
were used (for sequences of the primers and PCR reaction
conditions see [25]).
Amplification of luciferase mRNA: 1 µl of each cDNA (six
cDNAs was prepared, see above) was amplified in 25 µl
PCR containing 1× SYBR Green/ROX PCR Master Mix
(PA-012, SuperArray Bioscience Corp., Frederick, MD),
and 0.4 µM primers; 40 amplification cycles at 95°C for
20 s, 60°C for 60 s, and 82°C for 20 s (fluorescence
acquiring) was used. Primers specific for the luciferase
sequence (5'GCTTACTGGGACGAAGACGAAC3',
5'CTTGACTGGCGACGTAATCCAC3') amplified a 247 bp
PCR product.
Normalization of cytokine mRNAs quantity
To ensure correctness of the quantification we normalized
cytokine (IL-1β, IL-6 TNF-α, and GM-CSF) expression toPage 11 of 14
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whose expression was found to be stable in our previous
work [25]. After determining quantities of mRNAs (R0 val-
ues) of the three reference genes in each sample (using
tested methods of real-time PCR data analysis) the sample
normalization factor was calculated as a geometric mean
of the three R0 values. GeNorm software was utilized for
the calculation [13]. The amount of cytokine mRNA in
each sample (cytokine R0 value) was then divided by the
normalization factor of the sample.
Data analysis
The mathematical equations used in most methods for
analyzing data obtained from real-time PCR are derived
from the basic formula describing the PCR amplification
in the exponential phase of the reaction:
Xn = X0 × (E + 1)n (1)
where Xn is the amount of PCR product at cycle n, X0 is the
starting amount of PCR template (which we are interested
in) and E is the amplification efficiency which can have a
value between 0 (no amplification) and 1 (doubling of
the PCR product in each amplification cycle). In fluores-
cent real-time PCR it is assumed that accumulation of
reporter dye fluorescence (R, fluorescence readings after
background subtraction) is proportional to the accumula-
tion of PCR amplification product, and equation 1 can
then be written as:
Rn = R0 × (E + 1)n (2)
and starting fluorescence R0 can be then calculated as:
R0 = Rn/(E + 1)n (3)
where Rn is the intensity of reporter dye fluorescence (pro-
portional to the amount of PCR product) at cycle n, and
R0 is the theoretical starting fluorescence which is propor-
tional to the amount of starting PCR template. Thus, the
R0 value represents the target quantity expressed in arbi-
trary fluorescence units. There are several techniques
based on this equation which are used for calculating the
R0 value. In threshold-based techniques where "Ct" (the
number of amplification cycles needed to reach the fluo-
rescence threshold) is measured, "n" in Eq 3 can be
replaced by "Ct":
R0 = RCt/(E + 1)Ct (4)
"RCt" then represents the threshold fluorescence which
can be set for each of the compared amplifications indi-
vidually, or a threshold value (RCt) common for all com-
pared amplifications can be used. In the latter case, the
numerical value of RCt in Eq 4 can be ignored (replaced for
example by 1.0) and the R0 value can be calculated:
R0 = 1/(E + 1)Ct or R0 = (E + 1)-Ct (5)
Other possibilities to obtain the R0 and E values are tech-
niques which use relative standard curve, linear regression
(utilizing equations derived from the basic formula – Eq
1) or fitting the PCR process to the sigmoid function (see
below). The quantities determined from the relative
standard curve as well as the quantities determined with
the other methods were designated as „R0“ throughout the
manuscript.
Relative standard curve method
For each gene, standard cDNAs (see above) were ampli-
fied along with sample cDNAs in the same PCR run.
Standard curves were generated by Mx 3000P 2.0 software
(Stratagene). The threshold fluorescence common for all
compared samples was set into the exponential phase of
the amplifications by the Mx 3000P system. The target
mRNA quantity in each sample (R0) was determined from
the relative standard curve (using sample Ct values) and
expressed in arbitrary units corresponding to the dilution
factors of the standard RNA preparation. Amplification
efficiency (E) representative for each gene was determined
using equation of the standard curve:
Ct = -1/log (E + 1) × log Ro + log R/log (E + 1) (6)
E = 10-1/Slope - 1; slope = -1/log [E + 1] (7)
Comparative Ct method
Amplification efficiency (E) for each gene was determined
from the relative standard curve (see above). The Ct value
for each reaction was determined by the real-time PCR
system Mx3000P setting the threshold fluorescence (com-
mon for all compared samples) into the exponential
phase of the amplifications). The target mRNA quantity in
each sample (R0) was then calculated from equation 5.
LinRegPCR method
A computer program entitled LinRegPCR developed by
Ramakers et al.[7] utilizes linear regression analysis of flu-
orescence data from the exponential phase of PCR ampli-
fication to determine the target mRNA quantity (R0) as
well as the amplification efficiency (E). Following equa-
tions were used:
log R = log (E + 1) × n + log R0; intercept = log R0, slope = log 
[E + 1] (8)
R0 = 10Intercept (9)
E = 10Slope- 1 (10)Page 12 of 14
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sidering the number of data points, regression coefficient
and slope of the regression line) for the selection of the
exponential phase in each PCR amplification. We ana-
lyzed our fluorescence data using this software and
obtained the R0 and E values for each reaction. Since
ANOVA detected no significant differences in amplifica-
tion efficiencies between the sample groups (Sh, Un, A, B,
C) we also applied a combined analysis using an average
E value (arithmetical mean of E values of all samples). In
the combined analysis ("LinRegPCR-Ct method"), the R0
was calculated from equation 4 using the average E value
and threshold fluorescence values (R) with corresponding
Ct values (determined by the real-time PCR system
Mx3000P).
DART-PCR method
DART-PCR (Data Analysis for Real-Time PCR) Excel work-
book developed by Peirson et al.[8] determines the E
value of each individual reaction using linear regression
analysis of the fluorescence data from the exponential
phase of each amplification (Eq 10). For the selection of
the exponential phase a midpoint (M) for each PCR
amplification is calculated, using maximal and minimal
fluorescence levels. DART-PCR determines the Ct value
for each reaction, offering the possibility of using individ-
ual threshold fluorescences or a threshold fluorescence
common for all compared reactions (the second possibil-
ity was used in this study). Target mRNA quantity (R0) is
then determined using equation 4. One-way analysis of
variance (included as a component of DART-PCR work-
book) detected no significant differences in amplification
efficiencies between the sample groups (Sh, Un, A, B, C),
so we also used the average E value (arithmetical mean of
E values of all samples) for the R0 calculation in each sam-
ple. Since the DART-PCR requires inputting of fluores-
cence data in triplicates and our PCR reactions were
carried out in duplicates, we created the "third replicate"
as the mean value of our duplicate fluorescence readings.
Liu and Saint method using exponential model of PCR 
("Liu & Saint-exp method")
Two arbitrary fluorescence thresholds (lower R1 and
higher R2, common for all compared samples) were man-
ually set in the exponential phase of amplification curves
and corresponding Ct values (provided by the Mx 3000P)
were recorded. For the thresholds selection the semiloga-
rithmic graph of the amplification curves (log of fluores-
cences – log R, against cycle number – n) was used because
the exponential phase of PCR amplification can be simply
identified on the graph (fluorescent data acquired in the
exponential phase of the reaction produce a straight line
on the semilogarithmic graph). Amplification efficiency
(E) of each reaction was calculated using equation:
E = (R2/R1)1/(Ct2-Ct1) - 1 (11)
The target mRNA quantity (R0) was calculated using equa-
tion 4. One-way analysis of variance (ANOVA) detected
no significant differences in amplification efficiencies
between the sample groups (Sh, Un, A, B, C), so the aver-
age E value (arithmetical mean of E values of all samples)
was also used for the R0 calculation in each sample (using
equation 4).
Sigmoid curve-fitting (SCF) method
Raw fluorescences (i.e. fluorescences without background
subtraction) from Mx 3000P were fitted to the four-para-
metric sigmoid function using the nonlinear regression
function of SigmaPlot (Version 10, Systat Software, Rich-
mond, CA, USA). Following equations were used:
Rna = Rb + Rn = Rb + Rmax/1 + e-((n-n1/2)/k) (12)
R0 = Rmax/1 + e(n1/2/k) (13)
where Rna is the aggregate reaction fluorescence at cycle n,
Rb is the background reaction fluorescence, Rn is the fluo-
rescence generated by the PCR product at cycle n, Rmax is
the maximal fluorescence generated by the PCR product,
n1/2 is the cycle number at which fluorescence reaches half
of the Rmax, k describes the slope of the sigmoid curve.
Repetitive regression analyses with sequential removal of
the last amplification cycle (the cut-off cycle) were per-
formed until the curve fitting failed, due to insufficient
data. The R0 value was calculated at each curve-fitting
using equation 13. For all amplification curves, the graph
of dependence of the calculated R0 values on the cut-off-
cycle was constructed and the minimum R0 value was
selected as the resulting R0 value – the target mRNA rela-
tive quantity [11]. For the data treatment a macro for Sig-
maPlot provided by Qiu et al.[24] was utilized. In some
instances the cut-off cycle with the minimal R0 value was
located in the linear region of the amplification curve. The
resulting R0 value was then selected manually by shifting
the cut-off cycle into the region located between end of
the linear amplification and entry of the reaction into the
plateau phase (i.e. into "upper arc" of the amplification
curve).
Intra-assay and inter-assay variability
In the intra-assay variability experiment, fifteen replicate
PCR reactions amplifying IL-1β or IL-6 were ran. In the
inter-assay variability experiment, eight PCR reactions
amplifying IL-1β or IL-6 were ran in eight separate PCR
(Mx 3000P) runs. The fluorescent data obtained from
each reaction replicate were then transformed into mRNA
quantity (the R0 value) by the tested methods for real-time
PCR data analysis. Arithmetical means, standard devia-Page 13 of 14
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tions (SD) and coefficients of variation (CV) were then
calculated from the determined R0 values (15 and 8 repli-
cates for each gene, respectively).
Statistics
All statistics were performed using Statistica (StatSoft,
Tulsa, OK). To enable better comparison of the results
obtained from the different methods of real-time PCR
data analysis the values of target mRNA quantities (R0)
were transformed percentually (setting the median of R0
values of all samples as 100%). Differences in amplifica-
tion efficiencies between the sample groups were assessed
using one-way analysis of variance (ANOVA). The
Kruskal-Wallis test was used for the comparison of differ-
ences in normalized cytokine expression between groups,
and the Mann-Whitney U test was used to compare differ-
ences between the group of untreated colitic animals (Un)
and other groups of animals. Values of P < 0.05 were con-
sidered as significant.
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